1-20 of 374
transaminases
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Inotuzumab Ozogamicin

Talha Badar, MD, Aniko Szabo, PhD, Martha Wadleigh, MD, Michaela Liedtke, MD, Shukaib Arslan, MD, Caitlin Siebenaller, PharmD, Ibrahim Aldoss, MD, Elizabeth Schultz, Mehrdad Hefazi, MD, Mark Litzow, MD, Eric Kuo, Amy Wang, MD MPH, Emily K Curran, MD, Rory M Shallis, MD, Nikolai A. Podoltsev, MD PhD, Suresh Kumar Balasubramanian, MD, Jay Yang, MD, Ryan J. Mattison, MD, Madelyn Burkart, MD, Shira Dinner, Anjali S. Advani, MD, Ehab L. Atallah, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1302.
https://doi.org/10.1182/blood-2019-124882
Published: 2019
Journal Articles

Trial in Progress: Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Global Study of Fostamatinib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

Nichola Cooper, MD MRCP, Isabel Gorham, BS RN, Ann M. Lowe, MD, Robert P. Numerof, PhD, Sandy Tong, MD, David J. Kuter
Journal: Blood
Blood (2019) 134 (Supplement_1): 4800.
https://doi.org/10.1182/blood-2019-126544
Published: 2019
Journal Articles

Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Very Severe Veno-Occlusive Disease after Unmanipulated Haploidentical HSCT with Post-Transplant Cyclophosphamide

Ignacio Gómez-Centurión, MD, Nieves Dorado, MD, Rebeca Bailén, MD, Miguel Echenagusia, MD, Arturo Alvarez, MD, Gillen Oarbeascoa, MD, Cristina Muñoz, Javier Anguita, MD PhD, Jose L. Diez-Martin, MD PhD, Mi Kwon, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1981.
https://doi.org/10.1182/blood-2019-125828
Published: 2019
Journal Articles

Efficacy and Survival in Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma: A Randomized, Controlled, Multicenter and Open-Labled Study with Ddgp Regimen Versus SMILE Regimen

Xinhua Wang, MD PhD, Lei Zhang, Xiangli Liu, Xin Li, Ling Li, Xiaorui Fu, Zhenchang Sun, Jingjing Wu, Xudong Zhang, Jiaqin Yan, Yu Chang, Feifei Nan, Zhiyuan Zhou, Xiaolong Wu, Li Tian, Wencai Li, Hongwei Xue, Jinghua Wang, Liqun Zou, Liping Su, Yi Lu, Yanzhen Guo, Ken H. Young, Mingzhi Zhang
Journal: Blood
Blood (2019) 134 (Supplement_1): 463.
https://doi.org/10.1182/blood-2019-127811
Published: 2019
Journal Articles

Sequential CD19- and Bcma-Specific Chimeric Antigen Receptor T Cell Treatment for RRMM: Report from a Single Center Study

Lingzhi Yan, Zhi Yan, Jingjing Shang, Xiaolan Shi, Song Jin, Liqing Kang, Su Qu, Jin Zhou, Huizhu Kang, Ruju Wang, Ying Yao, Jing Wang, Weiqin Yao, Guanghua Chen, Lei Yu, Depei Wu, MD PhD, Fu Cheng Cheng, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 578.
https://doi.org/10.1182/blood-2019-129740
Published: 2019
Journal Articles

SWOG 1312 Final Results: A Phase 1 Trial of Inotuzumab in Combination with CVP (Cyclophosphamide, Vincristine, Prednisone) for Relapsed/ Refractory CD22+ Acute Leukemia

Anjali S. Advani, MD, Anna Moseley, M.S., Michaela Liedtke, MD, Margaret R O'Donnell, MD, Ibrahim Aldoss, MD, Martha P. Mims, MD PhD, Kristen Marie O'Dwyer, MD, Megan Othus, PhD, Harry P. Erba, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 227.
https://doi.org/10.1182/blood-2019-125340
Published: 2019
Journal Articles

Cytogenetic and Molecular Marker Associations to Outcomes with Duvelisib and Ofatumumab Treatment in Patients with Relapsed or Refractory CLL/SLL in the DUO Trial

Jennifer R Brown, MD PhD, Kam Sprott, PhD, Santosh Reddy, Stephanie Lustgarten, PhD, David T. Weaver, PhD, Alexey Danilov, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4312.
https://doi.org/10.1182/blood-2019-122491
Published: 2019
Journal Articles

Phase 1 Trial of Cladribine, High-Dose Cytarabine, G-CSF, and Dose-Escalated Mitoxantrone (CLAG-M) Plus Gemtuzumab Ozogamicin in Adults with Newly-Diagnosed Acute Myeloid Leukemia (AML) or Other High-Grade Myeloid Neoplasm

Colin D. Godwin, MDMPhil, Megan Othus, PhD, Mary-Elizabeth M. Percival, MD, Bart L. Scott, MD, Pamela S. Becker, MD PhD, Kelda M. Gardner, PA-C, Sioban B. Keel, MD, Tejaswini M. Dhawale, MD, Vivian G. Oehler, MD, Janis L. Abkowitz, MD, Anna B. Halpern, MD, Paul C. Hendrie, MD PhD, Kaysey F. Orlowski, Alice Woo, Elihu H. Estey, MD, Roland B. Walter, MD PhD MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 3892.
https://doi.org/10.1182/blood-2019-126009
Published: 2019
Journal Articles

Blinatumomab in Combination with Tyrosine Kinase Inhibitors Safely and Effectively Induces Rapid, Deep, and Durable Molecular Responses in Relapsed and Refractory Philadelphia Positive Acute Leukemias

James K McCloskey, MD, Joelle Gagnon, NP, Tara McCabe, FNP-C, MSN, RN, BSN, Jocelyn Charlon, MS, AGPCNP-BC, Shuqi Wang, MSc, Ruzong Fan, Stuart L. Goldberg, MD, Jamie Koprivnikar, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3812.
https://doi.org/10.1182/blood-2019-131838
Published: 2019
Journal Articles

The Real-Life Data on the Outcome of Hepatitis B Infection in Patients with B-Cell Lymphoproliferative Neoplasms Treated with Ibrutinib

Abdulkadir Ercaliskan, MD, Ahmet Emre Eskazan, MD, Nurgul Ozgur Yurttas, MD, Selin Kucukyurt, MD, Ayse Salihoglu, MD, Dilek Keskin, MD, Deniz Ozmen, MD, Tugrul Elverdi, MD, Muhlis Cem Ar, MD PhD, Teoman Soysal, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4316.
https://doi.org/10.1182/blood-2019-127794
Published: 2019
Journal Articles

Geranylgeranyl Diphosphate Synthase Inhibitor and Proteasome Inhibitor Combination Therapy in Multiple Myeloma

Staci L. Haney, PhD, Michelle L. Varney, MS, Lynette M. Smith, PhD, Sarah A. Holstein, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4417.
https://doi.org/10.1182/blood-2019-129244
Published: 2019
Journal Articles

Underdiagnosed Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome(VOD/SOS) As a Major Cause of Multi-Organ Failure in Acute Leukemia Transplant Patients: An Analysis from the EBMT Acute Leukemia Working Party

Abdul Hamid Bazarbachi, MD, Rama Al Hamed, MD, Myriam Labopin, MD, Kazimierz Halaburda, MD PhD, Hélène Labussière-Wallet, Paolo Bernasconi, MD, Wilfried Schroyens, MD PhD, Virginie Gandemer, MD PhD, Nicolaas Schaap, MD PhD, Pierre Simon Rohrlich, MD PhD, Pavel Jindra, MD PhD, John A Snowden, BSc (Hons), MBChB, MD FRCP, FRCPath, Depei Wu, MD PhD, Blandine Guffroy, Montserrat Rovira, MD, Sylvain Chantepie, MD, Xavier Poire, Dolores Caballero, MD PhD, Emmanouil Nikolousis, Mario Petrini, MD PhD, Fabio Ciceri, MD, Frédéric Baron, MD PhD, Ali Bazarbachi, MD PhD, Selim Corbacioglu, MD, Bipin N. Savani, MD, Zinaida Peric, MD PhD, Arnon Nagler, MD MSc, Enric Carreras, Mohamad Mohty, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4483.
https://doi.org/10.1182/blood-2019-124065
Published: 2019
Journal Articles

The Combination of Nilotinib + Pegylated IFN Alpha 2a Provides Somewhat Higher Cumulative Incidence Rates of MR4.5 at M36 Versus Nilotinib Alone in Newly Diagnosed CP CML Patients. Updated Results of the Petals Phase III National Study.

Franck E Nicolini, MD PhD, Gabriel Etienne, MD PhD, Francoise Huguet, MD, Agnès Guerci-Bresler, MD PhD, Aude Charbonnier, MD PhD, Martine Escoffre-Barbe, MD, Viviane Dubruille, MD, Hyacinthe Johnson-Ansah, MD, Laurence Legros, MD PhD, Valerie Coiteux, MD, Pascale Cony-Makhoul, MD, Pascal Lenain, MD, Lydia Roy, MD, Philippe Rousselot, MD PhD, Denis Guyotat, MD PhD, Jean-Christophe Ianotto, MD PhD, Martine Gardembas, MD, Eric Deconinck, MD PhD, Fabrice Larosa, MD, Denis Caillot, MD, Pascal Turlure, MD, Stephane Courby, MD, Philippe Quittet, MD, Eric Hermet, MD, Shanti Ame, MD, Simona Lapusan, MD, Alexandre Deloire, CRA, Stephane Morisset, BioStat, Madeleine Etienne, CRA, Delphine Rea, MD, Stephanie Dulucq, PharmD, PhD, Francois-Xavier Mahon, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 494.
https://doi.org/10.1182/blood-2019-123674
Published: 2019
Journal Articles

Original Versus Generic Lenalidomide in Patients with Relapsed Multipl Myeloma: Comprasion of Effectivity and Adverse Events

Zahit Bolaman, Sehmus Ertop, Atakan Turgutkaya, Selim Cem, Ayse Hilal Eroglu Kucukerdiler, Birsen Sahip, Irfan Yavasoglu, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5594.
https://doi.org/10.1182/blood-2019-131093
Published: 2019
Journal Articles

Nilotinib Vs Nilotinib Plus Pegylated Interferon α (Peg-IFN) Induction and Nilotinib or Peg-IFN Maintenance Therapy for Newly Diagnosed BCR-ABL1 Positive Chronic Myeloid Leukemia Patients in Chronic Phase (TIGER Study): The Addition of Peg-IFN Is Associated with Higher Rates of Deep Molecular Response

Andreas Hochhaus, MD, Andreas Burchert, MD, Susanne Saussele, MD, Gabriela M Baerlocher, MD, Tim H Brümmendorf, MD, Paul La Rosée, MD, Dominik Heim, MD, Stefan W Krause, MD, Philipp D le Coutre, MD, Dietger Niederwieser, MD, Thoralf Lange, MD, Alice Fabarius, PhD, Mathias Hänel, MD, Frank Stegelmann, MD, Jiri Mayer, MD, Arthur Gil, MPH, Danny Himsel, MSc, Joerg Hasford, MD, Rüdiger Hehlmann, MD, Thomas Ernst, MD, Christian Fabisch, Dr.rer.MDc., Markus Pfirrmann, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 495.
https://doi.org/10.1182/blood-2019-130043
Published: 2019
Journal Articles

High Expression of BCAT1 promotes Acute Myeloid Leukemia Progression and Sensitize to PARP Inhibitor

Jie Jin, PhD, Jie Jin, PhD, Jiajia Pan, Yungui Wang, PhD, Shujuan Huang, Shihui Mao, Qing Ling, Jinghan Wang, MD PhD, Chenying Li
Journal: Blood
Blood (2019) 134 (Supplement_1): 5041.
https://doi.org/10.1182/blood-2019-125221
Published: 2019
Journal Articles

Retrospective Non-Interventional Assessment of the Use of Idelalisib in Relapsed/Refractory Chronic Lymphocytic Leukemia Patients in Spain

Christelle M Ferra, Manuel Perez Encinas, MD, Javier Lopez Jimenez, MD, Macarena Ortiz, MD, Santiago Osorio-Prendes, MD, Raul Cordoba, MD PhD, Angel Ramirez Payer, Eva González-Barca, MD PhD, Guillermo Martín Sánchez, MD, Marcos Gonzalez Diaz, MD, Maria Jose Sanchez, MD, Margarita Fernandez, MD, Patricia Baltasar Tello, MD, Elena Amutio, MD, María-Dolores García-Malo, MD, Maria Jesus Vidal Maceñido, MD, Pascual Fernandez, MD, Javier Loscertales, MD, Juan Nicolás Rodríguez, MD, Concha Alaez, MD, Heribert Ramroth, PhD, Margarida Palla
Journal: Blood
Blood (2019) 134 (Supplement_1): 5473.
https://doi.org/10.1182/blood-2019-126588
Published: 2019
Journal Articles

Safe Use of Hydroxyurea in Sickle Cell Disease Patients Hospitalized for Painful Vaso-Occlusive Episodes: Results of the Randomized, Open-Label Helps Study

Nicola Conran, PhD, Kleber Yotsumoto Fertrin, MD PhD, Claudia de Alvarenga Maximo, MD, Thais Oliveira, B.Sc., Clarisse Lobo, MD PhD, Fernando Ferreira Costa, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2303.
https://doi.org/10.1182/blood-2019-130106
Published: 2019
Journal Articles

A Phase I Study of Single-Agent Inotuzumab Ozogamicin in Pediatric CD22-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia: Preliminary Results of the ITCC-059 Study

Erica Brivio, MD, Marta Lopez-Yurda, PhD, Cormac Ownes, MD, Cristina Díaz de Heredia, MD PhD, Bella Bielorai, MD, Claudia Rossig, Vincent van der Velden, PhD, Anneke C.J. Ammerlaan, Inge M. van der Sluis, MD PhD, Monique L. Den Boer, PhD, Ying Chen, Barbara Sleight, MD, Benoit Brethon, MD, Karsten Nysom, Jan Stary, Prof., MD PhD, Ingrid Øra, Christiane Chen-Santel, Luciana Vinti, MD, Franco Locatelli, MD PhD, Christian Michel Zwaan, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2629.
https://doi.org/10.1182/blood-2019-122411
Published: 2019
Journal Articles

Veno-Occlusive Disease (VOD) after Hematopoietic Stem Cell Transplant (HSCR): Always a Catastrophic Illness?

Paolo Bernasconi, MD, Anna Amelia Colombo, MD, Daniela Caldera, MD, Oscar Borsani, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5649.
https://doi.org/10.1182/blood-2019-125608
Published: 2019